MedPath

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease

Phase 1
Withdrawn
Conditions
Cytomegalovirus Infections
Cytomegalovirus Retinitis
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Registration Number
NCT00000881

A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection

Not Applicable
Completed
Conditions
Mycobacterium Avium-intracellulare Infection
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
85
Registration Number
NCT00000895
Locations
🇺🇸

Case Western Reserve Univ, Cleveland, Ohio, United States

🇺🇸

Ohio State Univ Hosp Clinic, Columbus, Ohio, United States

🇺🇸

Univ of Pennsylvania at Philadelphia, Philadelphia, Pennsylvania, United States

and more 23 locations

Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive Children

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
103
Registration Number
NCT00000893
Locations
🇺🇸

The Children's Hosp. of Philadelphia IMPAACT CRS, Philadelphia, Pennsylvania, United States

🇺🇸

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS, Los Angeles, California, United States

🇺🇸

Bronx-Lebanon Hosp. IMPAACT CRS, Bronx, New York, United States

and more 24 locations

Dexamethasone in Cryptococcal Meningitis

Phase 2
Completed
Conditions
Meningitis, Cryptococcal
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-28
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
36
Registration Number
NCT00000776
Locations
🇺🇸

Northwestern Univ Med School, Chicago, Illinois, United States

🇺🇸

Cook County Hosp, Chicago, Illinois, United States

🇺🇸

Univ of Miami School of Medicine, Miami, Florida, United States

and more 11 locations

A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants

Phase 1
Completed
Conditions
Pneumococcal Infections
HIV Infections
Interventions
Biological: Pneumococcal Vaccine, Polyvalent (23-valent)
Biological: Pneumococcal Conjugate Vaccine, Heptavalent
Biological: Placebo
First Posted Date
2001-08-31
Last Posted Date
2021-10-28
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
60
Registration Number
NCT00000829
Locations
🇺🇸

The Children's Hosp. of Philadelphia IMPAACT CRS, Philadelphia, Pennsylvania, United States

🇺🇸

SUNY Upstate Med. Univ., Dept. of Peds., Syracuse, New York, United States

🇺🇸

UMDNJ - Robert Wood Johnson, New Brunswick, New Jersey, United States

and more 30 locations

Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.

Phase 1
Completed
Conditions
HIV Infections
Anus Neoplasms
First Posted Date
2001-08-31
Last Posted Date
2021-10-28
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
98
Registration Number
NCT00000764
Locations
🇺🇸

University of Washington AIDS CRS, Seattle, Washington, United States

Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents

Phase 1
Completed
Conditions
HIV Infections
Interventions
First Posted Date
2001-08-31
Last Posted Date
2021-11-05
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
195
Registration Number
NCT00006604
Locations
🇺🇸

Rush Univ. Cook County Hosp. Chicago NICHD CRS, Chicago, Illinois, United States

🇺🇸

Children's Med. Ctr. Dallas, Dallas, Texas, United States

🇺🇸

Univ. of California San Francisco NICHD CRS, San Francisco, California, United States

and more 33 locations

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
80
Registration Number
NCT00001044
Locations
🇺🇸

JHU AVEG, Pittsburgh, Pennsylvania, United States

🇺🇸

St. Louis Univ. School of Medicine AVEG, Saint Louis, Missouri, United States

🇺🇸

Univ. of Rochester AVEG, Rochester, New York, United States

and more 1 locations

A Phase I/II Study of Delayed-Type Hypersensitivity (DTH) Reactions to Intradermal HIV Envelope Antigen

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
50
Registration Number
NCT00000782
Locations
🇺🇸

Stanford CRS, Palo Alto, California, United States

🇺🇸

Santa Clara Valley Med. Ctr., San Jose, California, United States

🇺🇸

San Mateo County AIDS Program, San Mateo, California, United States

and more 1 locations

A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides

Phase 3
Completed
Conditions
Pneumonia, Pneumocystis Carinii
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
700
Registration Number
NCT00000802
Locations
🇺🇸

Case CRS, Cleveland, Ohio, United States

🇺🇸

Ucsd, Avrc Crs, San Diego, California, United States

🇺🇸

Univ. of Miami AIDS CRS, Miami, Florida, United States

and more 41 locations
© Copyright 2025. All Rights Reserved by MedPath